Wholesale, export & individual medicine enquiriesenquiry@cureivahealthcare.com
← Back to medicines
Tadalafil 20 mg – Tastylia Oral Strips
MEDICINE ENQUIRY

Tadalafil 20 mg – Tastylia Oral Strips

Request availability and a quotation for your required quantity and destination.

ProductTadalafil 20 mg – Tastylia Oral Strips
CategoriesCialis / Tadalafil, Erectile Dysfunction
AvailabilityConfirmed on enquiry

Product listing is not a recommendation to use this medicine. Prescription and destination requirements apply where relevant.

Tadalafil 20 mg – Tastylia Oral Strips

Listed ingredient: Tadalafil 20 mg. Dosage form: Oral Strips. Exact manufacturer identity, formulation and batch must be checked against original packaging.

Medical information

Tadalafil is a PDE5 inhibitor that may be prescribed for erectile dysfunction after clinician assessment. Sexual stimulation is required; country-specific product authorisation varies.

Safety

Do not combine PDE5 inhibitors with nitrates or riociguat due to dangerous hypotension. Discuss cardiovascular disease, liver and kidney problems, alpha-blockers and other drug interactions with a prescriber. Seek urgent care for sudden vision or hearing loss, chest pain or an erection persisting for four hours.

Explore more Tadalafil brands

Browse Tadalafil products and brands · Erectile Dysfunction catalogue

Frequently asked questions

What does Tastylia 20 mg contain?

The marketed composition is Tadalafil 20 mg; verify the original manufacturer pack.

Is a prescription required?

Consult a clinician and follow local prescription and import rules.

Can it be taken with nitrate medicines?

No. Serious hypotension may occur.

Can it be used with other ED medicines?

Do not combine PDE5 inhibitors without specialist advice.

Enquiry catalogue only; authenticity, availability and regulatory compliance must be confirmed before supply.

Related patient education: Read sildenafil vs tadalafil: differences, timing and safety. The article primarily discusses standard oral tablets; it does not establish that this oral jelly or strip formulation has equivalent absorption or regulatory approval. A clinician must assess suitability and possible interactions, including the contraindication with nitrate medicines.

WhatsApp